Click a link below to view the mailing archive as if it had been sent to you.
| 2026-01-30 12:15 | | AstraZeneca leans into obesity, striking wide-ranging alliance with China’s CSPC and more... |
| 2026-01-30 00:15 | | The biopharma industry outlook on 2026: Optimism and tension and more... |
| 2026-01-29 12:15 | | Drugmakers Roche and Sanofi talk up their pipelines, as earnings fail to excite and more... |
| 2026-01-29 00:15 | | Hair loss biotech Veradermics sets terms for $200 million IPO and more... |
| 2026-01-28 12:15 | | Novo's Wegovy and Ozempic US advertising spend doubles rival Eli Lilly, data shows and more... |
| 2026-01-28 00:15 | | Trump admin rolls out 15 high-profile drugs for IRA price cuts and more... |
| 2026-01-27 12:15 | | Roche claims obesity drug caused 22.5% weight loss as it aims to catch up with Lilly, Novo and more... |
| 2026-01-27 00:15 | | Medtronic, Boston Sci Join 60+ CEOs in Calling for ‘Immediate Deescalation’ in Minneapolis and more... |
| 2026-01-26 12:15 | | Biopharma layoffs surged last year, but 2026 is a chance to turn the page and more... |
| 2026-01-26 00:15 | | Novo Nordisk sued in US for allegedly monopolizing diabetes drug Victoza and more... |
| 2026-01-23 12:15 | | Sanofi’s Dupixent successor heads to regulators after Phase III success and more... |
| 2026-01-23 00:15 | | US withdraws from the World Health Organization and more... |
| 2026-01-22 12:15 | | FDA lays out new path to speed development of multiple myeloma drugs and more... |
| 2026-01-22 00:15 | | Corvus shares nearly triple on positive data for eczema pill and more... |
| 2026-01-21 12:15 | | Insilico agrees on $66M deal to split rights for preclinical NLRP3 inhibitor with new Chinese biotech and more... |
| 2026-01-21 00:15 | | GSK licenses Alteogen enzyme in bid to develop subQ Jemperli and more... |
| 2026-01-20 12:15 | | GSK to buy Rapt in $2.2B deal for food allergy drug and more... |
| 2026-01-19 12:15 | | After AbbVie and Genmab's ph. 3 survival miss for Epkinly in DLBCL, what's next? and more... |
| 2026-01-16 12:15 | | Novo shares jump on ‘encouraging’ Wegovy pill scripts data, analysts say and more... |
| 2026-01-16 00:15 | | JPM26: Leo Pharma’s growth strategy puts a spotlight on rare dermatology diseases and more... |
| 2026-01-15 12:15 | | Boston Scientific to acquire Penumbra for $14.5B and more... |
| 2026-01-15 00:15 | | JPM26: Paying cash for obesity drugs, renewed IPO optimism and pharma’s cell therapy view and more... |
| 2026-01-14 12:15 | | JPM26: AstraZeneca's $80B revenue target 'very much within reach,' CFO says and more... |
| 2026-01-14 00:15 | | JPM26: Biotech’s M&A lift, the ‘new’ Biogen and Merck’s $70B target and more... |
| 2026-01-13 12:15 | | FDA requests removal of suicide warning from GLP-1 drugs and more... |
| 2026-01-13 00:15 | | JPM26: US biotech’s ‘Sputnik moment,’ Pfizer’s obesity ambitions and Bristol Myers’ big year and more... |
| 2026-01-12 12:15 | | Early signals from our AI survey: use is growing, confidence is not and more... |
| 2026-01-12 00:15 | | FTC wins ruling blocking Edwards Lifesciences' acquisition of JenaValve and more... |
| 2026-01-09 12:15 | | Why JPM 2026 will mark the end of the healthcare deal drought and more... |
| 2026-01-09 00:15 | | Lilly touts promise of Zepbound-Taltz combo in patients with obesity and psoriatic arthritis and more... |
| 2026-01-08 12:15 | | Biopharmas axed 47% more employees year over year and more... |
| 2026-01-08 00:15 | | Lilly snaps up Ventyx for $1.2B in pursuit of oral immune drugs and more... |
| 2026-01-07 12:15 | | Lilly's prospective cardiometabolic launches dominate list of drugs to watch in 2026: Clarivate and more... |
| 2026-01-07 00:15 | | AZ looks to grow reach in lupus with phase 3 win for self-administered Saphnelo and more... |
| 2026-01-06 12:15 | | Amgen buys protein-degrading startup Dark Blue for up to $840M and more... |
| 2026-01-06 00:15 | | Lilly’s Path to $94B in Revenue Rests on Oral Obesity Market and Other 2026 Milestones and more... |
| 2026-01-05 12:15 | | First GLP-1 pill for obesity from Novo Nordisk launches in the U.S. and more... |
| 2026-01-02 12:15 | | Pfizer leads industry-wide surge in drug prices for 2026 despite political pressure and more... |
